{"pmid":32504463,"title":"Battling COVID-19 in Bangladesh: A Conversation with Dr. John Clemens of icddr,b.","text":["Battling COVID-19 in Bangladesh: A Conversation with Dr. John Clemens of icddr,b.","Battling COVID-19 in Bangladesh: A Conversation with Dr. John Clemens of icddr,b.","Am J Trop Med Hyg","32504463"],"abstract":["Battling COVID-19 in Bangladesh: A Conversation with Dr. John Clemens of icddr,b."],"journal":"Am J Trop Med Hyg","date":"2020-06-07T11:00:00Z","year":2020,"_id":"32504463","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.4269/ajtmh.20-0504","locations":["Bangladesh","Bangladesh"],"countries":["Bangladesh"],"countries_codes":["BGD|Bangladesh"],"weight":0,"_version_":1668892488248590336,"score":9.490897,"similar":[{"pmid":32425713,"pmcid":"PMC7233240","title":"COVID-19 pandemic: Response plan by the Johns Hopkins Aramco Healthcare inpatient pharmacy department.","text":["COVID-19 pandemic: Response plan by the Johns Hopkins Aramco Healthcare inpatient pharmacy department.","The coronavirus disease 2019 (COVID-19) is an ongoing pandemic having caused a major health care crises across the globe.Pharmacy professionals are considered vital in preparation for optimal response to the COVID-19 pandemic. Therefore, in response to the estimated potential impact of COVID-19 on Johns Hopkins Aramco Healthcare (joint venture between Saudi Aramco and Johns Hopkins Medicine International), several initiatives were taken by the hospital's inpatient pharmacy department with focus on infection control, staffing, meeting clinical operational challenges, ethics, increased utilization of automation, and maintenance of employee wellness to prepare for this challenge. The plan implemented by the inpatient pharmacy department was prepared while incorporating information and recommendations from leading pharmacy organizations, ministry of health, institute's experience in battling another similar coronavirus (the Middle East respiratory syndrome-coronavirus) previously, and updated scientific research. The key focus areas include development of an institutionalized COVID-19 protocol, measures to improve infection control when handling and dispensing medications, modified staffing plan, system changes in peri-operative areas, keeping pharmacy professionals updated about new and scientific researches, increased utilization of automation, clinical interventions by pharmacist ensuring appropriate utilization of medications while monitoring for drug-drug interactions, adverse drug event prevention, and preparing for handling drug shortages. By implementing a robust plan, pharmacy professionals continue to show that they are an integral member of inter-professional health care teams.","Res Social Adm Pharm","Arain, Savera","Thalapparambath, Rajesh","Al Ghamdi, Fuad Hamed","32425713"],"abstract":["The coronavirus disease 2019 (COVID-19) is an ongoing pandemic having caused a major health care crises across the globe.Pharmacy professionals are considered vital in preparation for optimal response to the COVID-19 pandemic. Therefore, in response to the estimated potential impact of COVID-19 on Johns Hopkins Aramco Healthcare (joint venture between Saudi Aramco and Johns Hopkins Medicine International), several initiatives were taken by the hospital's inpatient pharmacy department with focus on infection control, staffing, meeting clinical operational challenges, ethics, increased utilization of automation, and maintenance of employee wellness to prepare for this challenge. The plan implemented by the inpatient pharmacy department was prepared while incorporating information and recommendations from leading pharmacy organizations, ministry of health, institute's experience in battling another similar coronavirus (the Middle East respiratory syndrome-coronavirus) previously, and updated scientific research. The key focus areas include development of an institutionalized COVID-19 protocol, measures to improve infection control when handling and dispensing medications, modified staffing plan, system changes in peri-operative areas, keeping pharmacy professionals updated about new and scientific researches, increased utilization of automation, clinical interventions by pharmacist ensuring appropriate utilization of medications while monitoring for drug-drug interactions, adverse drug event prevention, and preparing for handling drug shortages. By implementing a robust plan, pharmacy professionals continue to show that they are an integral member of inter-professional health care teams."],"journal":"Res Social Adm Pharm","authors":["Arain, Savera","Thalapparambath, Rajesh","Al Ghamdi, Fuad Hamed"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425713","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.sapharm.2020.05.016","locations":["Saudi Aramco"],"topics":["Prevention"],"weight":1,"_version_":1667252837660229633,"score":87.55476},{"pmid":32501147,"title":"Geriatric Health in Bangladesh during COVID-19: Challenges and Recommendations.","text":["Geriatric Health in Bangladesh during COVID-19: Challenges and Recommendations.","The novel coronavirus disease (COVID-19) is impacting health globally, whereas older adults are highly susceptible and more likely to have adverse health outcomes. In Bangladesh, the elderly population has been increasing over the past few decades, who often live with poor socioeconomic conditions and inadequate access to healthcare services. These disparities are likely to increase amid COVID-19, which may result in high mortality and morbidity among Bangladeshi older adults. We recommend that multifaceted interventions should be adopted for strengthening social care and health systems approach to ensure wellbeing, promote preventive measures, and facilitate access to healthcare among older adults in Bangladesh. Such multipronged measures would require policy-level commitment and collaborative efforts of health and social care providers and institutions to protect health and wellbeing among this vulnerable population during the COVID-19 pandemic.","J Gerontol Soc Work","Hossain, Md Mahbub","Mazumder, Hoimonty","Tasnim, Samia","Nuzhath, Tasmiah","Sultana, Abida","32501147"],"abstract":["The novel coronavirus disease (COVID-19) is impacting health globally, whereas older adults are highly susceptible and more likely to have adverse health outcomes. In Bangladesh, the elderly population has been increasing over the past few decades, who often live with poor socioeconomic conditions and inadequate access to healthcare services. These disparities are likely to increase amid COVID-19, which may result in high mortality and morbidity among Bangladeshi older adults. We recommend that multifaceted interventions should be adopted for strengthening social care and health systems approach to ensure wellbeing, promote preventive measures, and facilitate access to healthcare among older adults in Bangladesh. Such multipronged measures would require policy-level commitment and collaborative efforts of health and social care providers and institutions to protect health and wellbeing among this vulnerable population during the COVID-19 pandemic."],"journal":"J Gerontol Soc Work","authors":["Hossain, Md Mahbub","Mazumder, Hoimonty","Tasnim, Samia","Nuzhath, Tasmiah","Sultana, Abida"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32501147","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1080/01634372.2020.1772932","keywords":["aging","bangladesh","coronavirus","covid-19","geriatrics","older adults"],"locations":["Bangladesh","Bangladesh","Bangladesh"],"countries":["Bangladesh"],"countries_codes":["BGD|Bangladesh"],"topics":["Prevention"],"weight":1,"_version_":1668890966437658624,"score":84.92854},{"pmid":32426318,"pmcid":"PMC7203732","title":"COVID-19 and Bangladesh: Challenges and How to Address Them.","text":["COVID-19 and Bangladesh: Challenges and How to Address Them.","As the coronavirus outbreak quickly surges worldwide, many countries are adopting non-therapeutic preventive measures, which include travel bans, remote office activities, country lockdown, and most importantly, social distancing. However, these measures face challenges in Bangladesh, a lower-middle-income economy with one of the world's densest populations. Social distancing is difficult in many areas of the country, and with the minimal resources the country has, it would be extremely challenging to implement the mitigation measures. Mobile sanitization facilities and temporary quarantine sites and healthcare facilities could help mitigate the impact of the pandemic at a local level. A prompt, supportive, and empathic collaboration between the Government, citizens, and health experts, along with international assistance, can enable the country to minimize the impact of the pandemic.","Front Public Health","Anwar, Saeed","Nasrullah, Mohammad","Hosen, Mohammad Jakir","32426318"],"abstract":["As the coronavirus outbreak quickly surges worldwide, many countries are adopting non-therapeutic preventive measures, which include travel bans, remote office activities, country lockdown, and most importantly, social distancing. However, these measures face challenges in Bangladesh, a lower-middle-income economy with one of the world's densest populations. Social distancing is difficult in many areas of the country, and with the minimal resources the country has, it would be extremely challenging to implement the mitigation measures. Mobile sanitization facilities and temporary quarantine sites and healthcare facilities could help mitigate the impact of the pandemic at a local level. A prompt, supportive, and empathic collaboration between the Government, citizens, and health experts, along with international assistance, can enable the country to minimize the impact of the pandemic."],"journal":"Front Public Health","authors":["Anwar, Saeed","Nasrullah, Mohammad","Hosen, Mohammad Jakir"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32426318","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3389/fpubh.2020.00154","keywords":["covid-19","community mitigation","healthcare","infection prevention and control","non-therapeutic intervention","novel coronavirus","testing"],"locations":["Bangladesh"],"countries":["Bangladesh"],"countries_codes":["BGD|Bangladesh"],"topics":["Prevention"],"weight":1,"_version_":1667352728927469570,"score":78.75998},{"pmid":32451351,"title":"Dr. Balevic, et al, reply.","text":["Dr. Balevic, et al, reply.","We read with great interest the very thoughtful commentary by Drs. Joob and Wiwanitkit. We agree with the authors that, despite conflicting clinical data to date, it is possible that HCQ may have a protective effect in the setting of COVID-19. More importantly, we agree that optimal HCQ dosage and timing is a critical underpinning for clinical trials. However, we highlight several considerations regarding treatment with high dose HCQ.","J Rheumatol","Balevic, Stephen J","Hornik, Christoph P","Green, Thomas P","Clowse, Megan E B","Gonzalez, Daniel","Maharaj, Anil R","Schanberg, Laura E","Eudy, Amanda M","Swamy, Geeta K","Hughes, Brenna L","Cohen-Wolkowiez, Michael","32451351"],"abstract":["We read with great interest the very thoughtful commentary by Drs. Joob and Wiwanitkit. We agree with the authors that, despite conflicting clinical data to date, it is possible that HCQ may have a protective effect in the setting of COVID-19. More importantly, we agree that optimal HCQ dosage and timing is a critical underpinning for clinical trials. However, we highlight several considerations regarding treatment with high dose HCQ."],"journal":"J Rheumatol","authors":["Balevic, Stephen J","Hornik, Christoph P","Green, Thomas P","Clowse, Megan E B","Gonzalez, Daniel","Maharaj, Anil R","Schanberg, Laura E","Eudy, Amanda M","Swamy, Geeta K","Hughes, Brenna L","Cohen-Wolkowiez, Michael"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32451351","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3899/jrheum.200681","e_drugs":["Hydroxychloroquine"],"weight":0,"_version_":1667881798552518656,"score":77.00473},{"pmid":32363143,"pmcid":"PMC7194830","title":"COVID-19: A case report from Bangladesh perspective.","text":["COVID-19: A case report from Bangladesh perspective.","A 34-year-old man without any significant medical history or comorbidities, suddenly developed fever, and shortness of breath, thereby admitted to the emergency department of a tertiary care hospital, Dhaka, Bangladesh. He had neither a history of traveling to Coronavirus disease (COVID) prone areas nor a direct contact of COVID positive patients. His chest X-ray revealed ground-glass opacity in the right middle and lower zone of the lung. The first polymerase chain reaction (PCR) test on throat and nasal swabs for the COVID upon admission was negative. Based on the chest X-ray result, RT-PCR was done again resulted positive. The patient was primarily treated with chloroquine and azithromycin. On full recovery, he was discharged from the hospital on day 12, after two subsequent throat swab samples tested negative by PCR (24 hours apart). He was encouraged to maintain home quarantine for at least the next 14 days. SARS-CoV-2 RNA by swab remained negative and the blood sample shows the presence of antibody (both IgM and IgG) in his follow-up visit (after 7 days of hospital discharge).","Respir Med Case Rep","Jahan, Yasmin","Rahman, Sohel","Rahman, Atiqur","32363143"],"abstract":["A 34-year-old man without any significant medical history or comorbidities, suddenly developed fever, and shortness of breath, thereby admitted to the emergency department of a tertiary care hospital, Dhaka, Bangladesh. He had neither a history of traveling to Coronavirus disease (COVID) prone areas nor a direct contact of COVID positive patients. His chest X-ray revealed ground-glass opacity in the right middle and lower zone of the lung. The first polymerase chain reaction (PCR) test on throat and nasal swabs for the COVID upon admission was negative. Based on the chest X-ray result, RT-PCR was done again resulted positive. The patient was primarily treated with chloroquine and azithromycin. On full recovery, he was discharged from the hospital on day 12, after two subsequent throat swab samples tested negative by PCR (24 hours apart). He was encouraged to maintain home quarantine for at least the next 14 days. SARS-CoV-2 RNA by swab remained negative and the blood sample shows the presence of antibody (both IgM and IgG) in his follow-up visit (after 7 days of hospital discharge)."],"journal":"Respir Med Case Rep","authors":["Jahan, Yasmin","Rahman, Sohel","Rahman, Atiqur"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32363143","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.rmcr.2020.101068","locations":["Dhaka","Bangladesh"],"countries":["Bangladesh"],"countries_codes":["BGD|Bangladesh"],"e_drugs":["Chloroquine","Azithromycin"],"topics":["Case Report"],"weight":1,"_version_":1666138496046202881,"score":72.733795}]}